跳至主要内容
临床试验/RBR-56twgz
RBR-56twgz进行中(未招募)未知

Efficacy of the Hypolipid Diet to control Dyslipidemia in patients with Antiphospholipid Syndrome - APS

Centro de Hematologia e Hemoterapia de Campinas - Hemocentro0 个研究点开始时间: 2020年2月13日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 70Y(—)

入选标准

  • Subjects were selected from patients diagnosed with thrombosis associated with primary APS, followed at the Hemostasis outpatient clinic of the State University of Campinas (UNICAMP). All patients with primary APS and dyslipidemia who had a history of arterial or venous thrombosis of both sexes, aged over 18 years and diagnosed with dyslipidemia were included.
  • The criteria for the diagnosis of dyslipidemia were: LDL-c above 100mg / dL, HDL-c below 40mg / dL (men) and 50mg / dL (women), TG above 200mg / dL, TC above 190mg / dL , non-HDL cholesterol above 130mg / dL or still on low-fat medications. LDL-c values above 100mg / dL were considered because they were patients with a history of thrombotic disease.

排除标准

  • Patients diagnosed with systemic autoimmune disease or neoplasia were excluded from the study.

研究者

发起方
Centro de Hematologia e Hemoterapia de Campinas - Hemocentro

相似试验